Based on previous studies reporting that atrogin-1 expression sensitively reflects the degree of sarcopenia, this study selected atrogin-1 as a representative marker of anti-sarcopenic effects and focused on analyzing its expression changes [8,39]. The gene discussed is FBXO32; the disease is sarcopenia.